In conclusion, cell cycle deregulation may influence the pathogenesis of AD through multiple pathways: 1) through phosphorylation and processing of APP to generate Aβ leading to plaque formation, 2) through Aβ and C-terminal fragment of APP inducing tau hyperphosphorylation [66,74-76], and 3) through both Aβ and P-APP affecting cell cycle deregulation and contributing to the unwarranted progression of cell cycle. This evidence concerns the gene APP and Alzheimer disease.